American Portfolios Advisors Rubius Therapeutics, Inc. Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Rubius Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 325 shares of RUBY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325
Holding current value
$0
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$0.46 - $1.29 $149 - $419
325 New
325 $141,000
Q2 2020

Mar 24, 2023
SELL
$4.01 - $6.88 $1,952 - $3,350
-487 Closed
0 $0
Q1 2020

Mar 24, 2023
BUY
$3.74 - $9.84 $605 - $1,594
162 Added 49.85%
487 $2.17 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email